NovaBridge Biosciences (NBP) Long-Term Investments (2020 - 2025)

NovaBridge Biosciences (NBP) has reported Long-Term Investments for 6 consecutive years, with $37.2 million the latest figure, recorded in Q4 2025.

• Quarterly Long-Term Investments rose 20.82% year-over-year to $37.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.2 million (up 20.82% YoY) and the FY2025 annual result came in at $37.2 million, up 20.82% from the prior year.
• Long-Term Investments slipped to $37.2 million in Q4 2025 per NBP's latest filing, from $40.3 million in the prior quarter.
• Over the last five years, Long-Term Investments for NBP reached as high as $55.1 billion in Q4 2021 and fell as low as $1.6 million in Q2 2023.
• A 5-year average of $5.0 billion and a median of $32.5 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2021 — Long-Term Investments jumped 424764.78% — and 2022, when it slumped 99.99%.
• Year by year, Long-Term Investments stood at $55.1 billion in 2021, then sank by 99.99% to $4.3 million in 2022, then sank by 61.31% to $1.7 million in 2023, then jumped by 1736.91% to $30.8 million in 2024, then rose by 20.82% to $37.2 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $37.2 million, $40.3 million, and $34.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.